康臣葯業：2023年度報告.pdf

1、Kidney Medicines腎科藥物Hepatobiliary Medicines肝膽藥物Orthopedics Medicines骨科藥物Dermatologic Medicines皮膚科藥物Contrast Medium對比劑Gastroenterology Medicines消化系統藥物Gynaecology and Paediatric Medicines婦兒藥物Corporate Information公司資料2-4Chairmans Statement主席報告5-14Financial Highlights財務摘要15Management Discussion and Anal

2、ysis管理層討論及分析16-26Directors and Senior Management Profile董事及高層管理人員履歷27-36Corporate Governance Report企業管治報告37-61Report of Directors董事局報告62-88Independent Auditors Report獨立核數師報告89-99Consolidated Statement of Profit or Loss綜合損益表100Consolidated Statement of Profit or Loss andOther Comprehensive Income綜合損益

3、及其他全面收益表101Consolidated Statement of Financial Position綜合財務狀況表102-103Consolidated Statement of Changes in Equity綜合權益變動表104-105Consolidated Cash Flow Statement綜合現金流量表106Notes to the Consolidated Financial Statements綜合財務報表附註107-235Five-Year Financial Summary五年財務摘要236Contents 目錄CONSUN PHARMACEUTICAL GR

4、OUP LIMITED 康臣葯業集團有限公司2CONSUN PHARMACEUTICAL GROUP LIMITED 康臣葯業集團有限公司2公司資料Corporate InformationDIRECTORSExecutive DirectorsMr.An Meng(Chairman,and appointed as the Chief Executive Officer on 17 January 2024)Ms.Li Qian(Vice Chairlady and Chief Executive Officer)(resigned,effective from 17 January 202

5、4)Professor Zhu QuanMr.Xu HanxingNon-Executive DirectorDr.Zhang LihuaIndependent Non-Executive DirectorsMr.Feng ZhongshiMs.Chen YujunMr.Su Yuanfu(resigned,effective from 25 March 2024)AUDIT COMMITTEEMs.Chen Yujun(Committee Chairlady)Dr.Zhang Lihua(appointed on 25 March 2024)Mr.Feng ZhongshiMr.Su Yua

6、nfu(resigned,effective from 25 March 2024)NOMINATION COMMITTEEMr.Feng Zhongshi(Committee Chairman)(appointed on 25 March 2024)Mr.An MengMs.Chen YujunMr.Su Yuanfu(Committee Chairman)(resigned,effective from 25 March 2024)REMUNERATION COMMITTEEMr.Feng Zhongshi(Committee Chairman)Mr.An MengMs.Chen Yuju